Share Price and Basic Stock Data
Last Updated: February 12, 2026, 8:56 pm
| PEG Ratio | -4.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Jubilant Ingrevia Ltd, operating in the agricultural products industry, reported a market capitalization of ₹10,703 Cr and a current share price of ₹672. The company has shown fluctuating revenue trends over recent quarters, with sales peaking at ₹1,158 Cr in December 2022 but declining to ₹966 Cr by December 2023. The trailing twelve months (TTM) sales stood at ₹4,267 Cr, a slight decrease from ₹4,773 Cr reported for the year ending March 2023. Annual sales have experienced a gradual decline from ₹4,949 Cr in March 2022 to ₹4,136 Cr in March 2024, indicating potential challenges in maintaining growth in a competitive market. Seasonal variations and external market conditions likely contributed to the observed revenue fluctuations. The company’s performance in the agricultural sector must be closely monitored as it navigates through these changing dynamics.
Profitability and Efficiency Metrics
Profitability metrics for Jubilant Ingrevia Ltd reflect a mixed performance. The operating profit margin (OPM) stood at 12% as of the latest reporting, with quarterly OPM fluctuating between 8% and 14% over the last year, indicating variability in operational efficiency. The net profit for the year ending March 2025 was reported at ₹251 Cr, with a net profit margin of 6.01%. However, the return on equity (ROE) stood at 8.58%, which is relatively low compared to sector expectations, while the return on capital employed (ROCE) was reported at 10.99%. The company’s cash conversion cycle (CCC) averaged 75 days, suggesting room for improvement in working capital management. Although the company has demonstrated the ability to generate profits, the efficiency ratios indicate that there are challenges to overcome in enhancing profitability and cost management.
Balance Sheet Strength and Financial Ratios
The balance sheet of Jubilant Ingrevia Ltd reveals a robust equity capital of ₹16 Cr and reserves amounting to ₹3,025 Cr. The company’s total borrowings stood at ₹806 Cr, reflecting a low long-term debt-to-equity ratio of 0.12, indicating prudent financial management. The interest coverage ratio (ICR) was reported at 10.01x, suggesting that the company comfortably meets its interest obligations. The price-to-book value (P/BV) ratio was recorded at 3.51x, which may indicate overvaluation compared to typical sector ranges. The current ratio stood at 1.32, demonstrating sufficient liquidity. However, the asset turnover ratio of 0.85 indicates that the company may not be utilizing its assets as efficiently as possible. Overall, while the balance sheet appears solid, there are signs of inefficiencies that could be addressed to improve financial health.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Jubilant Ingrevia Ltd reflects a diverse ownership structure, with promoters holding 45.22% of the shares as of September 2025, a decline from 51.47% earlier in the year. Foreign institutional investors (FIIs) accounted for 5.96%, while domestic institutional investors (DIIs) increased their stake to 23.04%, indicating growing confidence among domestic investors. The public’s stake stood at 24.94%. The number of shareholders increased to 1,25,749, suggesting sustained interest in the company despite fluctuations in promoter holdings. This diversification may enhance the company’s resilience against market volatility. However, the reduction in promoter holding could raise concerns about long-term strategic control. Maintaining investor confidence will be crucial as the company addresses its operational challenges and seeks to stabilize revenue growth.
Outlook, Risks, and Final Insight
Looking ahead, Jubilant Ingrevia Ltd faces both opportunities and challenges. The company must focus on enhancing operational efficiency to improve profitability margins while managing its revenue fluctuations. Risks include potential market volatility in the agricultural sector and the impact of rising input costs, which could further strain margins. Additionally, the decline in promoter shareholding may signal uncertainties regarding management’s long-term vision. On the other hand, the company’s strong balance sheet and growing institutional interest provide a solid foundation for future growth. If Jubilant Ingrevia can effectively manage its operational challenges and leverage its financial position, it may be well-positioned to navigate the competitive landscape and enhance shareholder value. The strategic focus on innovation and efficiency will be essential to achieving sustainable growth in the coming years.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| GRM Overseas Ltd | 3,371 Cr. | 163 | 186/65.8 | 62.3 | 23.5 | 0.00 % | 12.1 % | 14.6 % | 2.00 |
| Freshtrop Fruits Ltd | 144 Cr. | 181 | 200/105 | 64.4 | 165 | 0.00 % | 7.35 % | 8.07 % | 10.0 |
| City Crops Agro Ltd | 35.1 Cr. | 21.5 | 28.2/16.8 | 15.8 | 0.00 % | 8.46 % | 8.14 % | 10.0 | |
| Chamanlal Setia Exports Ltd | 1,363 Cr. | 275 | 396/228 | 13.5 | 153 | 0.91 % | 16.7 % | 14.2 % | 2.00 |
| Mangalam Global Enterprise Ltd | 413 Cr. | 12.4 | 18.5/11.3 | 14.9 | 6.86 | 0.08 % | 16.8 % | 14.6 % | 1.00 |
| Industry Average | 3,834.70 Cr | 240.60 | 29.83 | 106.69 | 0.33% | 11.80% | 12.33% | 4.00 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,158 | 1,145 | 1,075 | 1,020 | 966 | 1,074 | 1,024 | 1,045 | 1,057 | 1,051 | 1,038 | 1,121 | 1,051 |
| Expenses | 1,007 | 1,043 | 958 | 902 | 871 | 983 | 915 | 921 | 918 | 905 | 896 | 985 | 924 |
| Operating Profit | 151 | 102 | 117 | 118 | 96 | 91 | 110 | 124 | 138 | 147 | 142 | 135 | 127 |
| OPM % | 13% | 9% | 11% | 12% | 10% | 8% | 11% | 12% | 13% | 14% | 14% | 12% | 12% |
| Other Income | 7 | 9 | 8 | 9 | 9 | 10 | 10 | 10 | 9 | 8 | 11 | 11 | -4 |
| Interest | 7 | 6 | 11 | 13 | 15 | 14 | 14 | 15 | 12 | 14 | 13 | 12 | 12 |
| Depreciation | 30 | 30 | 32 | 34 | 34 | 36 | 39 | 40 | 40 | 39 | 41 | 41 | 45 |
| Profit before tax | 122 | 76 | 81 | 80 | 55 | 51 | 66 | 80 | 96 | 102 | 100 | 93 | 65 |
| Tax % | 25% | 31% | 29% | 28% | 30% | 43% | 26% | 26% | 27% | 27% | 25% | 25% | 28% |
| Net Profit | 92 | 52 | 58 | 57 | 39 | 29 | 49 | 59 | 69 | 74 | 75 | 69 | 47 |
| EPS in Rs | 5.75 | 3.28 | 3.62 | 3.61 | 2.42 | 1.84 | 3.06 | 3.70 | 4.36 | 4.65 | 4.71 | 4.36 | 2.94 |
Last Updated: February 5, 2026, 8:46 am
Below is a detailed analysis of the quarterly data for Jubilant Ingrevia Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 1,051.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,121.00 Cr. (Sep 2025) to 1,051.00 Cr., marking a decrease of 70.00 Cr..
- For Expenses, as of Dec 2025, the value is 924.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 985.00 Cr. (Sep 2025) to 924.00 Cr., marking a decrease of 61.00 Cr..
- For Operating Profit, as of Dec 2025, the value is 127.00 Cr.. The value appears to be declining and may need further review. It has decreased from 135.00 Cr. (Sep 2025) to 127.00 Cr., marking a decrease of 8.00 Cr..
- For OPM %, as of Dec 2025, the value is 12.00%. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 12.00%.
- For Other Income, as of Dec 2025, the value is -4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 11.00 Cr. (Sep 2025) to -4.00 Cr., marking a decrease of 15.00 Cr..
- For Interest, as of Dec 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 12.00 Cr..
- For Depreciation, as of Dec 2025, the value is 45.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 41.00 Cr. (Sep 2025) to 45.00 Cr., marking an increase of 4.00 Cr..
- For Profit before tax, as of Dec 2025, the value is 65.00 Cr.. The value appears to be declining and may need further review. It has decreased from 93.00 Cr. (Sep 2025) to 65.00 Cr., marking a decrease of 28.00 Cr..
- For Tax %, as of Dec 2025, the value is 28.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Sep 2025) to 28.00%, marking an increase of 3.00%.
- For Net Profit, as of Dec 2025, the value is 47.00 Cr.. The value appears to be declining and may need further review. It has decreased from 69.00 Cr. (Sep 2025) to 47.00 Cr., marking a decrease of 22.00 Cr..
- For EPS in Rs, as of Dec 2025, the value is 2.94. The value appears to be declining and may need further review. It has decreased from 4.36 (Sep 2025) to 2.94, marking a decrease of 1.42.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:07 am
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 0 | 684 | 4,949 | 4,773 | 4,136 | 4,178 | 4,267 |
| Expenses | 0 | 567 | 4,108 | 4,224 | 3,708 | 3,658 | 3,704 |
| Operating Profit | -0 | 117 | 841 | 549 | 427 | 519 | 562 |
| OPM % | 17% | 17% | 11% | 10% | 12% | 13% | |
| Other Income | 0 | -10 | 22 | 32 | 29 | 38 | 40 |
| Interest | 0 | 7 | 31 | 22 | 53 | 56 | 51 |
| Depreciation | 0 | 22 | 123 | 122 | 136 | 158 | 161 |
| Profit before tax | -0 | 77 | 709 | 437 | 268 | 344 | 390 |
| Tax % | 0% | 30% | 33% | 30% | 32% | 27% | |
| Net Profit | -0 | 54 | 477 | 308 | 183 | 251 | 288 |
| EPS in Rs | -3.40 | 3.41 | 29.93 | 19.31 | 11.48 | 15.77 | 18.08 |
| Dividend Payout % | 0% | 10% | 17% | 26% | 43% | 31% |
YoY Net Profit Growth
| Year | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|
| YoY Net Profit Growth (%) | 783.33% | -35.43% | -40.58% | 37.16% |
| Change in YoY Net Profit Growth (%) | 0.00% | -818.76% | -5.15% | 77.74% |
Jubilant Ingrevia Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 4 years from 2021-2022 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -5% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 331% |
| 3 Years: | -20% |
| TTM: | 59% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 16% |
| 1 Year: | -1% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 12% |
| 3 Years: | 9% |
| Last Year: | 9% |
Last Updated: September 5, 2025, 8:35 am
Balance Sheet
Last Updated: December 4, 2025, 1:30 am
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.05 | 16 | 16 | 16 | 16 | 16 | 16 |
| Reserves | -0 | 1,907 | 2,417 | 2,650 | 2,722 | 2,911 | 3,025 |
| Borrowings | 0 | 556 | 238 | 407 | 740 | 764 | 806 |
| Other Liabilities | 0 | 888 | 1,111 | 1,176 | 1,241 | 1,324 | 1,410 |
| Total Liabilities | 0 | 3,366 | 3,782 | 4,249 | 4,719 | 5,015 | 5,257 |
| Fixed Assets | 0 | 1,805 | 1,798 | 1,846 | 2,539 | 2,581 | 2,611 |
| CWIP | 0 | 65 | 174 | 525 | 331 | 525 | 633 |
| Investments | 0 | 50 | 6 | 8 | 15 | 37 | 26 |
| Other Assets | 0 | 1,446 | 1,804 | 1,870 | 1,834 | 1,872 | 1,985 |
| Total Assets | 0 | 3,366 | 3,782 | 4,249 | 4,719 | 5,015 | 5,257 |
Below is a detailed analysis of the balance sheet data for Jubilant Ingrevia Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 16.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 16.00 Cr..
- For Reserves, as of Sep 2025, the value is 3,025.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,911.00 Cr. (Mar 2025) to 3,025.00 Cr., marking an increase of 114.00 Cr..
- For Borrowings, as of Sep 2025, the value is 806.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 764.00 Cr. (Mar 2025) to 806.00 Cr., marking an increase of 42.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1,410.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,324.00 Cr. (Mar 2025) to 1,410.00 Cr., marking an increase of 86.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 5,257.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5,015.00 Cr. (Mar 2025) to 5,257.00 Cr., marking an increase of 242.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 2,611.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,581.00 Cr. (Mar 2025) to 2,611.00 Cr., marking an increase of 30.00 Cr..
- For CWIP, as of Sep 2025, the value is 633.00 Cr.. The value appears strong and on an upward trend. It has increased from 525.00 Cr. (Mar 2025) to 633.00 Cr., marking an increase of 108.00 Cr..
- For Investments, as of Sep 2025, the value is 26.00 Cr.. The value appears to be declining and may need further review. It has decreased from 37.00 Cr. (Mar 2025) to 26.00 Cr., marking a decrease of 11.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,985.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,872.00 Cr. (Mar 2025) to 1,985.00 Cr., marking an increase of 113.00 Cr..
- For Total Assets, as of Sep 2025, the value is 5,257.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,015.00 Cr. (Mar 2025) to 5,257.00 Cr., marking an increase of 242.00 Cr..
Notably, the Reserves (3,025.00 Cr.) exceed the Borrowings (806.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Free Cash Flow | 0.00 | -439.00 | 603.00 | 142.00 | -313.00 | -245.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Debtor Days | 251 | 43 | 39 | 50 | 53 | |
| Inventory Days | 601 | 117 | 146 | 160 | 163 | |
| Days Payable | 685 | 103 | 113 | 131 | 141 | |
| Cash Conversion Cycle | 167 | 57 | 72 | 80 | 75 | |
| Working Capital Days | 220 | 49 | 42 | 37 | 29 | |
| ROCE % | 8% | 29% | 16% | 10% | 11% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| DSP Small Cap Fund | 7,000,000 | 2.91 | 492.42 | 5,188,657 | 2025-12-08 03:47:31 | 34.91% |
| DSP Mid Cap Fund | 4,469,774 | 1.61 | 314.43 | 3,926,722 | 2025-12-08 03:47:31 | 13.83% |
| Kotak Small Cap Fund | 3,629,417 | 1.48 | 255.31 | N/A | N/A | N/A |
| Axis Small Cap Fund | 2,578,209 | 0.68 | 181.36 | N/A | N/A | N/A |
| Franklin India Small Cap Fund | 1,600,000 | 0.85 | 112.55 | N/A | N/A | N/A |
| Edelweiss Small Cap Fund | 1,424,301 | 1.89 | 100.85 | N/A | N/A | N/A |
| Bandhan Small Cap Fund | 1,391,916 | 0.52 | 97.91 | N/A | N/A | N/A |
| UTI Small Cap Fund | 1,208,816 | 1.8 | 85.03 | 1,169,215 | 2026-01-26 07:43:17 | 3.39% |
| HDFC Manufacturing Fund | 1,205,150 | 0.77 | 84.78 | N/A | N/A | N/A |
| DSP Large Cap Fund | 1,146,659 | 1.11 | 80.66 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 15.89 | 11.56 | 19.34 | 29.98 | 20.78 |
| Diluted EPS (Rs.) | 15.84 | 11.55 | 19.34 | 29.97 | 20.78 |
| Cash EPS (Rs.) | 25.85 | 20.19 | 27.03 | 37.75 | 4.80 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 185.11 | 173.27 | 167.72 | 153.06 | 120.73 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 185.11 | 173.27 | 167.72 | 153.06 | 120.73 |
| Revenue From Operations / Share (Rs.) | 264.19 | 261.78 | 300.23 | 311.34 | 42.95 |
| PBDIT / Share (Rs.) | 35.22 | 28.89 | 36.52 | 54.31 | 7.52 |
| PBIT / Share (Rs.) | 25.25 | 20.27 | 28.83 | 46.55 | 6.13 |
| PBT / Share (Rs.) | 21.73 | 16.94 | 27.47 | 44.60 | 4.86 |
| Net Profit / Share (Rs.) | 15.89 | 11.57 | 19.35 | 29.99 | 3.41 |
| NP After MI And SOA / Share (Rs.) | 15.88 | 11.58 | 19.34 | 29.99 | 3.41 |
| PBDIT Margin (%) | 13.33 | 11.03 | 12.16 | 17.44 | 17.50 |
| PBIT Margin (%) | 9.55 | 7.74 | 9.60 | 14.95 | 14.27 |
| PBT Margin (%) | 8.22 | 6.47 | 9.15 | 14.32 | 11.31 |
| Net Profit Margin (%) | 6.01 | 4.42 | 6.44 | 9.63 | 7.94 |
| NP After MI And SOA Margin (%) | 6.01 | 4.42 | 6.44 | 9.63 | 7.94 |
| Return on Networth / Equity (%) | 8.58 | 6.68 | 11.53 | 19.59 | 2.82 |
| Return on Capital Employeed (%) | 10.99 | 9.29 | 14.88 | 26.96 | 3.93 |
| Return On Assets (%) | 4.99 | 3.86 | 7.22 | 12.55 | 1.60 |
| Long Term Debt / Equity (X) | 0.12 | 0.15 | 0.05 | 0.04 | 0.23 |
| Total Debt / Equity (X) | 0.25 | 0.26 | 0.14 | 0.09 | 0.23 |
| Asset Turnover Ratio (%) | 0.85 | 0.92 | 1.16 | 1.38 | 0.41 |
| Current Ratio (X) | 1.32 | 1.38 | 1.54 | 1.68 | 1.59 |
| Quick Ratio (X) | 0.64 | 0.65 | 0.66 | 0.81 | 0.91 |
| Inventory Turnover Ratio (X) | 4.43 | 4.19 | 2.84 | 4.08 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 31.80 | 43.18 | 25.84 | 9.52 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 19.54 | 24.75 | 18.49 | 7.56 | 0.00 |
| Earning Retention Ratio (%) | 68.20 | 56.82 | 74.16 | 90.48 | 0.00 |
| Cash Earning Retention Ratio (%) | 80.46 | 75.25 | 81.51 | 92.44 | 0.00 |
| Interest Coverage Ratio (X) | 10.01 | 8.67 | 26.90 | 27.91 | 16.34 |
| Interest Coverage Ratio (Post Tax) (X) | 5.52 | 4.47 | 15.25 | 16.41 | 10.18 |
| Enterprise Value (Cr.) | 10933.88 | 7789.81 | 6031.88 | 7331.49 | 4498.03 |
| EV / Net Operating Revenue (X) | 2.62 | 1.88 | 1.26 | 1.48 | 6.57 |
| EV / EBITDA (X) | 19.63 | 17.07 | 10.39 | 8.49 | 37.57 |
| MarketCap / Net Operating Revenue (X) | 2.46 | 1.73 | 1.20 | 1.44 | 6.08 |
| Retention Ratios (%) | 68.19 | 56.81 | 74.15 | 90.47 | 0.00 |
| Price / BV (X) | 3.51 | 2.61 | 2.15 | 2.94 | 2.16 |
| Price / Net Operating Revenue (X) | 2.46 | 1.73 | 1.20 | 1.44 | 6.08 |
| EarningsYield | 0.02 | 0.02 | 0.05 | 0.06 | 0.01 |
After reviewing the key financial ratios for Jubilant Ingrevia Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 15.89. This value is within the healthy range. It has increased from 11.56 (Mar 24) to 15.89, marking an increase of 4.33.
- For Diluted EPS (Rs.), as of Mar 25, the value is 15.84. This value is within the healthy range. It has increased from 11.55 (Mar 24) to 15.84, marking an increase of 4.29.
- For Cash EPS (Rs.), as of Mar 25, the value is 25.85. This value is within the healthy range. It has increased from 20.19 (Mar 24) to 25.85, marking an increase of 5.66.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 185.11. It has increased from 173.27 (Mar 24) to 185.11, marking an increase of 11.84.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 185.11. It has increased from 173.27 (Mar 24) to 185.11, marking an increase of 11.84.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 264.19. It has increased from 261.78 (Mar 24) to 264.19, marking an increase of 2.41.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 35.22. This value is within the healthy range. It has increased from 28.89 (Mar 24) to 35.22, marking an increase of 6.33.
- For PBIT / Share (Rs.), as of Mar 25, the value is 25.25. This value is within the healthy range. It has increased from 20.27 (Mar 24) to 25.25, marking an increase of 4.98.
- For PBT / Share (Rs.), as of Mar 25, the value is 21.73. This value is within the healthy range. It has increased from 16.94 (Mar 24) to 21.73, marking an increase of 4.79.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 15.89. This value is within the healthy range. It has increased from 11.57 (Mar 24) to 15.89, marking an increase of 4.32.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 15.88. This value is within the healthy range. It has increased from 11.58 (Mar 24) to 15.88, marking an increase of 4.30.
- For PBDIT Margin (%), as of Mar 25, the value is 13.33. This value is within the healthy range. It has increased from 11.03 (Mar 24) to 13.33, marking an increase of 2.30.
- For PBIT Margin (%), as of Mar 25, the value is 9.55. This value is below the healthy minimum of 10. It has increased from 7.74 (Mar 24) to 9.55, marking an increase of 1.81.
- For PBT Margin (%), as of Mar 25, the value is 8.22. This value is below the healthy minimum of 10. It has increased from 6.47 (Mar 24) to 8.22, marking an increase of 1.75.
- For Net Profit Margin (%), as of Mar 25, the value is 6.01. This value is within the healthy range. It has increased from 4.42 (Mar 24) to 6.01, marking an increase of 1.59.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.01. This value is below the healthy minimum of 8. It has increased from 4.42 (Mar 24) to 6.01, marking an increase of 1.59.
- For Return on Networth / Equity (%), as of Mar 25, the value is 8.58. This value is below the healthy minimum of 15. It has increased from 6.68 (Mar 24) to 8.58, marking an increase of 1.90.
- For Return on Capital Employeed (%), as of Mar 25, the value is 10.99. This value is within the healthy range. It has increased from 9.29 (Mar 24) to 10.99, marking an increase of 1.70.
- For Return On Assets (%), as of Mar 25, the value is 4.99. This value is below the healthy minimum of 5. It has increased from 3.86 (Mar 24) to 4.99, marking an increase of 1.13.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.12. This value is below the healthy minimum of 0.2. It has decreased from 0.15 (Mar 24) to 0.12, marking a decrease of 0.03.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.25. This value is within the healthy range. It has decreased from 0.26 (Mar 24) to 0.25, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.85. It has decreased from 0.92 (Mar 24) to 0.85, marking a decrease of 0.07.
- For Current Ratio (X), as of Mar 25, the value is 1.32. This value is below the healthy minimum of 1.5. It has decreased from 1.38 (Mar 24) to 1.32, marking a decrease of 0.06.
- For Quick Ratio (X), as of Mar 25, the value is 0.64. This value is below the healthy minimum of 1. It has decreased from 0.65 (Mar 24) to 0.64, marking a decrease of 0.01.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.43. This value is within the healthy range. It has increased from 4.19 (Mar 24) to 4.43, marking an increase of 0.24.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 31.80. This value is within the healthy range. It has decreased from 43.18 (Mar 24) to 31.80, marking a decrease of 11.38.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 19.54. This value is below the healthy minimum of 20. It has decreased from 24.75 (Mar 24) to 19.54, marking a decrease of 5.21.
- For Earning Retention Ratio (%), as of Mar 25, the value is 68.20. This value is within the healthy range. It has increased from 56.82 (Mar 24) to 68.20, marking an increase of 11.38.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 80.46. This value exceeds the healthy maximum of 70. It has increased from 75.25 (Mar 24) to 80.46, marking an increase of 5.21.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 10.01. This value is within the healthy range. It has increased from 8.67 (Mar 24) to 10.01, marking an increase of 1.34.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 5.52. This value is within the healthy range. It has increased from 4.47 (Mar 24) to 5.52, marking an increase of 1.05.
- For Enterprise Value (Cr.), as of Mar 25, the value is 10,933.88. It has increased from 7,789.81 (Mar 24) to 10,933.88, marking an increase of 3,144.07.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.62. This value is within the healthy range. It has increased from 1.88 (Mar 24) to 2.62, marking an increase of 0.74.
- For EV / EBITDA (X), as of Mar 25, the value is 19.63. This value exceeds the healthy maximum of 15. It has increased from 17.07 (Mar 24) to 19.63, marking an increase of 2.56.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.46. This value is within the healthy range. It has increased from 1.73 (Mar 24) to 2.46, marking an increase of 0.73.
- For Retention Ratios (%), as of Mar 25, the value is 68.19. This value is within the healthy range. It has increased from 56.81 (Mar 24) to 68.19, marking an increase of 11.38.
- For Price / BV (X), as of Mar 25, the value is 3.51. This value exceeds the healthy maximum of 3. It has increased from 2.61 (Mar 24) to 3.51, marking an increase of 0.90.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.46. This value is within the healthy range. It has increased from 1.73 (Mar 24) to 2.46, marking an increase of 0.73.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Jubilant Ingrevia Ltd:
- Net Profit Margin: 6.01%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 10.99% (Industry Average ROCE: 11.8%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 8.58% (Industry Average ROE: 12.33%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 5.52
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.64
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 38.4 (Industry average Stock P/E: 29.83)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.25
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.01%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agricultural Products | Bhartiagram, Amroha District Uttar Pradesh 244223 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Shyam S Bhartia | Chairman |
| Mr. Hari S Bhartia | Co-Chairman & WholeTime Director |
| Mr. Deepak Jain | Managing Director & CEO |
| Mr. Priyavrat Bhartia | Director |
| Mr. Aashti Bhartia | Director |
| Mr. Vijay Kumar Srivastava | Whole Time Director |
| Mr. Sushil Kumar Roongta | Independent Director |
| Mr. Arun Seth | Independent Director |
| Mr. Pradeep Banerjee | Independent Director |
| Mr. Siraj Azmat Chaudhry | Independent Director |
| Ms. Ameeta Chatterjee | Independent Director |
| Ms. Sudha Pillai | Independent Director |
FAQ
What is the intrinsic value of Jubilant Ingrevia Ltd?
Jubilant Ingrevia Ltd's intrinsic value (as of 12 February 2026) is ₹474.65 which is 28.30% lower the current market price of ₹662.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹10,564 Cr. market cap, FY2025-2026 high/low of ₹852/535, reserves of ₹3,025 Cr, and liabilities of ₹5,257 Cr.
What is the Market Cap of Jubilant Ingrevia Ltd?
The Market Cap of Jubilant Ingrevia Ltd is 10,564 Cr..
What is the current Stock Price of Jubilant Ingrevia Ltd as on 12 February 2026?
The current stock price of Jubilant Ingrevia Ltd as on 12 February 2026 is ₹662.
What is the High / Low of Jubilant Ingrevia Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Jubilant Ingrevia Ltd stocks is ₹852/535.
What is the Stock P/E of Jubilant Ingrevia Ltd?
The Stock P/E of Jubilant Ingrevia Ltd is 38.4.
What is the Book Value of Jubilant Ingrevia Ltd?
The Book Value of Jubilant Ingrevia Ltd is 191.
What is the Dividend Yield of Jubilant Ingrevia Ltd?
The Dividend Yield of Jubilant Ingrevia Ltd is 0.76 %.
What is the ROCE of Jubilant Ingrevia Ltd?
The ROCE of Jubilant Ingrevia Ltd is 11.2 %.
What is the ROE of Jubilant Ingrevia Ltd?
The ROE of Jubilant Ingrevia Ltd is 8.88 %.
What is the Face Value of Jubilant Ingrevia Ltd?
The Face Value of Jubilant Ingrevia Ltd is 1.00.